Search - tctmd.com

Displaying 161 - 180 of 275

Sort: Relevancy | Date

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

News Daily News

La 1ª Estrategia ATP es Igual que la Implantación Primaria de un Stent en el Tratamiento de la Enfermedad de la Arteria Poplítea

Caitlin E. Cox

June 28, 2013

Presentation

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

Presenter: Aljoscha Rastan

June 05, 2013

News Conference News EuroPCR 2013

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

Jason Kahn

May 23, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

Presentation EuroPCR 2013

Mimics Study: Results at 12 Months

Presenter: Stephan H. Duda

May 21, 2013

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Daily News

Meta análisis: Los SLF son Beneficiosos pero podrían No salvar las Extremidades ni Mejorar la Supervivencia en Pacientes con EAP

May 03, 2013

Presentation

Meta-analysis: Outcomes of Endovascular Treatment of Infrapopliteal Occlusive Disease with DES

Presenter: George A. Antoniou

May 02, 2013

News Daily News

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

April 19, 2013

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

Presentation

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Presenter: Robert A. Lookstein

April 15, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

April 12, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

News Daily News

Los Pacientes Negros son Más Propensos a Sufrir Amputaciones en presencia de Isquemia Crítica de las Extremidades

March 28, 2013

News Daily News

Black Patients More Likely to Undergo Amputation for Critical Limb Ischemia

March 28, 2013

Presentation

Influence of Race on the Management of Lower Extremity Ischemia

Presenter: Tyler S. Durazzo

March 25, 2013

Advertisement

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

La 1ª Estrategia ATP es Igual que la Implantación Primaria de un Stent en el Tratamiento de la Enfermedad de la Arteria Poplítea

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

Paclitaxel Delivery Key to PAD Intervention

Mimics Study: Results at 12 Months

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Meta análisis: Los SLF son Beneficiosos pero podrían No salvar las Extremidades ni Mejorar la Supervivencia en Pacientes con EAP

Meta-analysis: Outcomes of Endovascular Treatment of Infrapopliteal Occlusive Disease with DES

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Los Pacientes Negros son Más Propensos a Sufrir Amputaciones en presencia de Isquemia Crítica de las Extremidades

Black Patients More Likely to Undergo Amputation for Critical Limb Ischemia

Influence of Race on the Management of Lower Extremity Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content